Publication:
Evaluation of Oxidative Stress, the Activities of Paraoxonase and Arylesterase in Patients With Subclinical Hypothyroidism

dc.contributor.authorsCebeci, Egemen; Alibaz-Oner, Fatma; Usta, Murat; Yurdakul, Selen; Erguney, Mecdi
dc.date.accessioned2022-03-12T18:07:22Z
dc.date.accessioned2026-01-10T17:51:46Z
dc.date.available2022-03-12T18:07:22Z
dc.date.issued2012
dc.description.abstractIntroduction: In subclinical hypothyroidism (SH), serum lipid and lipoprotein concentrations are frequently changed. Compared with the healthy population, the levels of oxidized low-density lipoprotein cholesterol are higher, and the levels of high-density lipoprotein cholesterol are lower. In patients with SH, the mechanism of atherosclerosis may beattributed to the lipid abnormalities. There is evidence showing that oxidation plays an important role during the process of atherosclerosis. Inthis study, we evaluated the activity of paraoxonase (PON) and arylesterase (ARE) in patients with SH and investigated their relation with oxidative stress. Methods: The study enrolled 25 patients with SH and 20 sex-and age-matched healthy controls. The patient group and the control group were compared in terms of the activity of PON and ARE and the oxidative stress index. Results: Between 2 groups, no significant difference was found in terms of age, sex, serum levels of total cholesterol, low-density lipoprotein, and high-density lipoprotein. In the SH group, the activity of PON was significantly lower than that observed in the control group (P < 0.05). Arylesterase activity also was significantly lower in the group with SH, compared with the control group (P < 0.05). Oxidative stress index was found to be significantly higher in the patient group, compared with the healthy subjects (P < 0.01). Oxidative stress index showed a strong positive correlation with the levels of thyroid stimulating hormone in all cases (r = 0.60, P < 0.01). Conclusions: The activity of PON and ARE were significantly decreased, and oxidative stress was increased in patients with SH. Lower activities of these 2 biomarkers indicate increased oxidative damage in SH. Atherosclerosis in SH can be attributed to increased oxidative stress.
dc.identifier.doidoiWOS:000298634400012
dc.identifier.eissn1708-8267
dc.identifier.issn1081-5589
dc.identifier.pubmed21997314
dc.identifier.urihttps://hdl.handle.net/11424/231009
dc.identifier.wosWOS:000298634400012
dc.language.isoeng
dc.publisherBMJ PUBLISHING GROUP
dc.relation.ispartofJOURNAL OF INVESTIGATIVE MEDICINE
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectsubclinical hypothyroidism
dc.subjectparaoxonase
dc.subjectarylesterase
dc.subjectatherosclerosis
dc.subjectoxidative stress
dc.subjectSERUM PARAOXONASE
dc.subjectTHYROID-HORMONE
dc.subjectDENSITY-LIPOPROTEIN
dc.subjectLIPID-PEROXIDATION
dc.subjectANTIOXIDANT STATUS
dc.subjectCHOLESTEROL LEVELS
dc.subjectDISEASE
dc.subjectATHEROSCLEROSIS
dc.subjectSUBSTITUTION
dc.subjectPREVALENCE
dc.titleEvaluation of Oxidative Stress, the Activities of Paraoxonase and Arylesterase in Patients With Subclinical Hypothyroidism
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage28
oaire.citation.issue1
oaire.citation.startPage23
oaire.citation.titleJOURNAL OF INVESTIGATIVE MEDICINE
oaire.citation.volume60

Files